Skip to main content
. 2019 Jan;27(1):23–33. doi: 10.1016/j.joca.2018.08.001

Table II.

Summary of outcome measures

Outcome measure category (n*) Primary outcomes Osteoarthritis and surrogate OA outcomes
Physical examination n = 30
  • 1.

    Laxity (n = 4)

  • 2.

    Patellofemoral stability (n = 2)

  • 3.

    Limb symmetry indices (n = 1)

  • 4.

    Torque (n = 1)

  • 5.

    Muscle electrical activity (n = 1)

  • 6.

    Functional – hop test (n = 1)

Patient reported n = 26
  • 1.

    Knee injury and Osteoarthritis Outcome Score (KOOS) (n = 5)

  • 2.

    Hospital for Special Surgery (HSS) knee score (n = 2)

  • 3.

    International Knee Documentation Committee (IKDC) Subjective Knee Form (n = 2)

  • 4.

    Kujala score (n = 2)

  • 5.

    The Knee Self-Efficacy Scale (K-SES) (n = 1)

  • 6.

    The Physical Activity Scale (n = 1)

  • 7.

    Tegner activity score (n = 1)

  • 8.

    Multidimensional Health Locus of Control (n = 1)

  • 1.

    Knee injury and Osteoarthritis Outcome Score (KOOS) (n = 1)

Imaging n = 43
  • 1.

    Radiographic: Kellgren–Lawrence classification (n = 1)

  • 2.

    CT: Quality of reduction (n = 1)

  • 3.

    MRI: Morphologic measures of articulating bone curvature (femur, tibia & trochlea) (n = 1)

  • 4.

    MRI: Cartilage thickness of femorotibial medial compartment (n = 1)

  • 5.

    MRI: Anterior Cruciate Ligament Osteoarthritis Score (ACLOS) (n = 1)

  • 1.

    Radiographic: Study specified criteria incl. joint space narrowing, osteophyte grade, subchondral sclerosis and sharpening of tibial spines (n = 4)

  • 2.

    Radiographic: Kellgren–Lawrence classification (n = 4)

  • 3.

    Radiographic: Ahlbäck classification (n = 2)

  • 4.

    Radiographic: modified OARSI grading scale for OA (n = 1)

  • 5.

    Radiographic: Medial joint space width (n = 1)

  • 6.

    Radiographic: Ahlbäck & Fairbank composite scale (n = 1)

  • 7.

    MRI: Whole Organ Magnetic Resonance Imaging Score (WORMS) (n = 1)

  • 8.

    MRI: Anterior Cruciate Ligament Osteoarthritis Score (ACLOAS) (n = 1)

  • 9.

    qMRI: Early matrix changes typical of arthritis (n = 1)

Biomarkers (n = 39) 1. GAG/proteoglycan marker: ARGS-aggrecan (n = 1)
Other (n = 9) 2. Safety, tolerability & adverse effects (n = 1)
TOTAL n = 147 Total = 21 primary outcomes Total = 10 measures

*where n = total number of studies with such measures.